These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 25497224

  • 1. Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery.
    Murata M, Piao JS, Narahara S, Kawano T, Hamano N, Kang JH, Asai D, Ugawa R, Hashizume M.
    Protein Expr Purif; 2015 Jun; 110():52-6. PubMed ID: 25497224
    [Abstract] [Full Text] [Related]

  • 2. Bacterial expression, purification, and in vitro N-myristoylation of fusion hepatitis B virus preS1 with the native-type N-terminus.
    Ma HH, Yang L, Yang XY, Xu ZP, Li BL.
    Protein Expr Purif; 2003 Jan; 27(1):49-54. PubMed ID: 12509984
    [Abstract] [Full Text] [Related]

  • 3. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM, Sominskaya I, Skrastina D, Pumpens P, El Wahed AA, Beutling U, Frank R, Fritz HJ, Hunsmann G, Gerlich WH, Glebe D.
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [Abstract] [Full Text] [Related]

  • 4. Expression and characterization of the preS1 peptide of hepatitis B surface antigen in Escherichia coli.
    Lin Y, Liu YX, Cislo T, Mason BL, Yu MY.
    J Med Virol; 1991 Mar; 33(3):181-7. PubMed ID: 1880495
    [Abstract] [Full Text] [Related]

  • 5. Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli.
    Maeng CY, Oh MS, Park IH, Hong HJ.
    Biochem Biophys Res Commun; 2001 Apr 06; 282(3):787-92. PubMed ID: 11401532
    [Abstract] [Full Text] [Related]

  • 6. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
    Gallina A, Gazina E, Milanesi G.
    Virology; 1995 Oct 20; 213(1):57-69. PubMed ID: 7483279
    [Abstract] [Full Text] [Related]

  • 7. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
    Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grün S, Bulavaite A, Sasnauskas K, Gerlich WH.
    Gastroenterology; 2005 Jul 20; 129(1):234-45. PubMed ID: 16012950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.
    Xu X, Li GD, Kong YY, Yang HL, Zhang Z, Cao HT, Wang Y.
    J Gen Virol; 1994 Dec 20; 75 ( Pt 12)():3673-7. PubMed ID: 7527840
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High level expression of hepatitis B virus preS1 peptide in Escherichia coli.
    Rhyum SB, Jin BR, Park HR, Hong HJ.
    J Biotechnol; 1994 Aug 31; 36(3):221-30. PubMed ID: 7765264
    [Abstract] [Full Text] [Related]

  • 15. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
    Argnani R, Boccafogli L, Marconi PC, Manservigi R.
    Gene Ther; 2004 Jul 31; 11(13):1087-98. PubMed ID: 15057264
    [Abstract] [Full Text] [Related]

  • 16. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
    Gripon P, Cannie I, Urban S.
    J Virol; 2005 Feb 31; 79(3):1613-22. PubMed ID: 15650187
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.